SCHEMBL25346041

SCHEMBL25346041

COc1cccc2cccc(-c3ccnc(Cl)c3F)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 2/20 0.40
▸ CYP3A4 P08684 3/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ AMY1A P0DUB6 2/20 0.40
▸ CYP17A1 P05093 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KCNA5 P22460 1/20 0.38
▸ TGFBR1 P36897 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1316078 0.80 KCNA5 (0.47) ALDH1A1MEN1KMT2AMAPTMAPK1
SCHEMBL30487262 0.78 CYP17A1 (0.37) CYP3A4CYP17A1CYP11B1CYP11B2ALDH1A1
SCHEMBL25347700 0.78 CYP17A1 (0.37) CYP3A4CYP17A1CYP11B1CYP11B2ALDH1A1
SCHEMBL28459550 0.74 AAK1 (0.40) CYP3A4MAPTMAPK1AAK1NPC1
SCHEMBL4370253 0.72 DYRK1A (0.38) CYP3A4CYP1A2CYP2D6CYP17A1CYP11B1
SCHEMBL11531700 0.71 IMPDH2 (0.40) CYP3A4CYP1A2CYP2D6ALDH1A1MEN1
SCHEMBL23943387 0.71 KDM1A (0.46) CYP3A4CYP1A2CYP2D6AMY1ACYP17A1
SCHEMBL27081351 0.70 KMO (0.37) CYP3A4CYP1A2MAPTMAPK1KDM4E
SCHEMBL29983520 0.70 KMO (0.37) CYP3A4CYP1A2MAPTMAPK1KDM4E
SCHEMBL27930027 0.70 KDM1A (0.45) FYNCYP3A4CYP1A2CYP2D6AMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116606322-A Organic electroluminescent material and device 环球展览公司 2023-08-18 — — CN disclosed
US-20230263048-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-08-17 — — US disclosed
US-20230263048-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-08-17 — — US disclosed
US-20230263048-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263048-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, ODC1 FYN 1753/4885CYP3A4 234/4885CYP1A2 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback